Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Prospective Randomized Clinical Trial of Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer

NCT05215379 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05215379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05215379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Prospective Randomized Clinical Trial of Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
Lead sponsor
Changhai Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
October 1, 2022
Completion date
June 24, 2025
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy, microsatellite instability low, neoadjuvant chemoradiation therapy, rectal cancer